Evaluation of Cerebrospinal Fluid Flow in Adolescent Idiopathic Scoliosis
NCT ID: NCT04760808
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
72 participants
OBSERVATIONAL
2021-02-10
2022-05-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to compare the CSF flow measured by magnetic resonance imaging (MRI) in an AIS group and a control group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Study of Functional and Morphometric Brain Abnormalities Related to Adolescent Idiopathic Scoliosis (MOR-FO-SIA)
NCT02302534
Dynamic MRI and Quantitative MR CSF Flow Studies in Craniovertebral Junction Anomalies
NCT00795080
Investigating the Potential Psychological Impact of Early Screening and Long-term Monitoring for Adolescent Idiopathic Scoliosis Among Patients and Caregivers
NCT05152329
Analysis of Disturbances in Neurofluid Dynamics in Type I Chiari Malformations
NCT06502431
Adolescent Idiopathic Scoliosis and Mental Health
NCT00445393
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AIS group
Baseline Clinical Examination
Evaluations of Postural control; Subjective postural vertical; Subjective visual vertical; Verticality perception
Initial 3T MRI of the Brain and Spine
Non-injected CSF flow MRI
6-month Follow-up Clinical Examination
Evaluations of Postural control; Subjective postural vertical; Subjective visual vertical; Verticality perception
6-month Follow-up 3T MRI of the Brain and Spine
Non-injected CSF flow MRI
Control Group
Baseline Clinical Examination
Evaluations of Postural control; Subjective postural vertical; Subjective visual vertical; Verticality perception
Initial 3T MRI of the Brain and Spine
Non-injected CSF flow MRI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Baseline Clinical Examination
Evaluations of Postural control; Subjective postural vertical; Subjective visual vertical; Verticality perception
Initial 3T MRI of the Brain and Spine
Non-injected CSF flow MRI
6-month Follow-up Clinical Examination
Evaluations of Postural control; Subjective postural vertical; Subjective visual vertical; Verticality perception
6-month Follow-up 3T MRI of the Brain and Spine
Non-injected CSF flow MRI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Affiliated to the French social security system
* Having signed the inform consent form
* Whose parents have given their consent
* Subject with right thoracic AIS defined by the existence of a 3D spine deformation with a frontal deviation to right dorsal convexity with a Cobb angle of at least 20°, and a rotation of at least 20°, as evidenced by the presence of a vertebral gibbosity ≥ 5° at the Bunnel scoliometer.
If the scoliosis has more than one curvature, the right chest curvature should be the greatest high (highest frontal Cobb angle)
* Subject with x-rays of total spine, face and profile under load, according to the EOS technique, dating from less than 3 months.
Exclusion Criteria
* At least 6 "cafe au lait" spots with a size ≥ 1.5 cm (may be suggestive of neurofibromatosis)
* Ligament hyperlaxity confirmed by a Beighton score \>4/9 (which may be suggestive of scoliosis secondary)
* Contraindications of a cerebro-medullary MRI: claustrophobia, foreign bodies, and ferrometallic clips of the trunk or cephalic segment, cochlear implants, stimulators and implantable cardiac defibrillators, insulin pump
* Inequality in length of the lower limbs ≥ 20 mm on clinical examination
* Subject presenting neurological signs (signs of pyramidal irritation, sensory-motor deficit, clinical signs suggestive of cerebellar pathology ...)
* Known vestibular pathology
* Taking psychotropic drugs
Additional exclusion criterion for the AIS group:
* Subject with secondary scoliosis : neurological, orthopedic, malformative...
Additional criteria for the control group:
* Subject with a scoliosis angle ≥ 10° on a photogrammetric screening assessment (optical process, non-irradiating, which allows an Morphometric evaluation of the trunk in 3D, thanks to the analysis of the trunk reliefs)
* Subject whose clinical examination shows a gibbosity measurable (\>5°) with the scoliometer of Bunnel
12 Years
17 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SSR pédiatrique Marc Sautelet
UNKNOWN
Lille Catholic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-François CATANZARITI, MD
Role: PRINCIPAL_INVESTIGATOR
SSR Marc Sautelet, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SSR Pédiatrique Marc Sautelet
Villeneuve-d'Ascq, Nord (59), France
GHICL Hôpital Saint Philibert, service d'Imagerie Médicale
Lomme, Nord, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC-P0093
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.